 |
|
Optimization of Exenatide plus Detemir Treatment for Morbid Obese Patients with Insulin Dependent Diabetes Resistant to Conventional Treatment. Effect of Exenatide on Patients with Mellitus Diabetes Type 2
Alfonso López Ruiz,
María Ángeles Núñez Sánchez,
Noelia Victoria García-Talavera Espín,
Amparo Meoro Avilés,
Cristina del Peso Gilsanz,
Ricardo Soriano Sánchez,
María Teresa Gallego García,
José Soriano Palao,
María Dolores Ortuño,
Sacramento Tomás Navarro,
Collaborative Groups of the Diabetes and Obesity Unit of the Hospital Reina Sofía
Pharmacol. Pharm. Vol.5 No.4, April 23, 2014
DOI:10.4236/pp.2014.54053
Exenatide Response in an Adolescent’s Morbid Obesity
Ricardo Soriano Sánchez,
Alfonso López Ruiz,
M. Ángeles Núñez Sánchez,
Noelia Victoria García-Talavera Espín,
Amparo Meoro Avilés,
María Teresa Gallego García,
Cristina del Peso Gilsanz,
José Soriano Palao,
Collaborative Groups of the Diabetes Obesity Unit of the Hospital Reina Sofía
Pharmacol. Pharm. Vol.5 No.4, April 23, 2014
DOI:10.4236/pp.2014.54051
Assessment of Arterial Stiffness Index in Hypertensive Patients in Relation to Their Treatment Status Attending a Tertiary Care Center in South India
Shourya Kola,
Melvin George,
Suresh Kumar Srinivasamurthy,
Sandhiya Selvarajan,
Kadhiravan Tamilarasu,
Rathinam Palamalai Swaminathan,
Adithan Chandrasekaran
Pharmacol. Pharm. Vol.5 No.4, April 22, 2014
DOI:10.4236/pp.2014.54050